Stock quote - Summary

Shield Therapeutics
STX: 50.50 -1.50 ( -2.88 %) delayed: 16:57PM
Bid price 50.00 High price 51.60
Ask price 51.00 Low price 50.30
Open price 51.60 Spread 1.96%
Prev close 50.50 Volume 33,399

Shield Therapeutics - Share price charts

Intraday
Historic - 6 months

Advanced Shield Therapeutics charts >

Shield Therapeutics - Share price information
Name Shield Therapeutics Epic STX
Activities Shield Therapeutics plc is a commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients' unmet medical needs. Our clear purpose is to help our patients become people again, by enabling them to enjoy the things that make the difference in their everyday lives. The Group has a marketed product, Feraccru, for the treatment of IDA in adult patients with IBD which has exclusive IP rights until the mid-2030's. ISIN GB00BYV81293
Latest Share Price (p) 50.50 Net Gearing (%) -21.21
Market Capitalisation (pm) 60.54 Gross Gearing (%) 8.37
Shares in issue (m) 116.43 Debt Ratio 0.00
P/E Ratio -3.06 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.09
Dividend Yield (%) 0.00 Price to book value 1.47
Dividend Cover 0.00 ROCE (%) -50.93
Earning per share (p) -17.00 EPS Growth (%) -13.33
52-week high / low (p) 63.00 / 15.10 DPS Growth (%) n/a
Shield Therapeutics - Broker views
Date Broker Recommendation Price Old target price New target price Notes
01 Feb Peel Hunt Buy 70.00 - Reiterates
29 Jan Peel Hunt Buy 70.00 - Reiterates
29 Jan Liberum Capital Buy 80.00 - Reiterates
24 Jan Peel Hunt Buy 70.00 - Reiterates
22 Jan Peel Hunt Buy 70.00 - Reiterates

More Shield Therapeutics broker views >

Shield Therapeutics - Director deals
Date Director Type Volume / Price Trade value
24 Sep 2018 Carl Sterritt Buy 88,235 @ 34.00p £29,999.90
05 Oct 2017 Carl Sterritt Buy 8,814 @ 100.00p £8,814.00

More Shield Therapeutics director deals >

Risk warning: Remember the price of shares can go down as well as up, and you are not guaranteed to get back the amount that you originally invested.
Click here to read the full warning.